NOTCH1 is a driver of T-cell acute lymphoblastic leukemia that can be inhibited by γ-secretase inhibitors (GSIs), but their clinical efficacy is limited. This evidence concerns the gene NOTCH1 and T-cell acute lymphoblastic leukemia.